# Assessment Of Dose-Dependent Immunomodulatory Effect Of Alveofact With or Without Steroisd In Neonatal RDS

> **NCT06367881** · PHASE1 · UNKNOWN · sponsor: **Ain Shams University** · enrollment: 60 (estimated)

## Conditions studied

- Neonatal Respiratory Distress Syndrome
- Inflammatory Response
- Premature Lungs
- Neutrophil Extracellular Trap Formation
- Preterm Birth

## Interventions

- **DRUG:** Alveofact
- **DRUG:** Budesonide

## Key facts

- **NCT ID:** NCT06367881
- **Lead sponsor:** Ain Shams University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-08-18
- **Primary completion:** 2024-07
- **Final completion:** 2024-10
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2024-04-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06367881

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06367881, "Assessment Of Dose-Dependent Immunomodulatory Effect Of Alveofact With or Without Steroisd In Neonatal RDS". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06367881. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*